Investments
33Portfolio Exits
15Funds
6About Envest Private Equity
Envest is a provider of early-stage capital to basic industries in the eastern portion of the United States. Envest invests in a relatively broad range of basic industries including healthcare, franchising, manufacturing, software, retail, business services, and non-revolutionary technologies.
Want to inform investors similar to Envest Private Equity about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Envest Private Equity Investments
33 Investments
Envest Private Equity has made 33 investments. Their latest investment was in NuScriptRX as part of their Series D - II on March 3, 2015.
Envest Private Equity Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/18/2015 | Series D - II | NuScriptRX | $3.85M | No | 1 | |
11/7/2014 | Series E | EndoChoice | $57M | No | 2 | |
7/2/2014 | Series D | NuScriptRX | $11M | Yes | 2 | |
8/6/2013 | Series B - III | |||||
6/25/2013 | Series A |
Date | 3/18/2015 | 11/7/2014 | 7/2/2014 | 8/6/2013 | 6/25/2013 |
|---|---|---|---|---|---|
Round | Series D - II | Series E | Series D | Series B - III | Series A |
Company | NuScriptRX | EndoChoice | NuScriptRX | ||
Amount | $3.85M | $57M | $11M | ||
New? | No | No | Yes | ||
Co-Investors | |||||
Sources | 1 | 2 | 2 |
Envest Private Equity Portfolio Exits
15 Portfolio Exits
Envest Private Equity has 15 portfolio exits. Their latest portfolio exit was MiniLuxe on December 06, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
12/6/2021 | Reverse Merger | 1 | |||
4/14/2021 | Acq - Fin | 2 | |||
5/2/2019 | Acquired | 6 | |||
Date | 12/6/2021 | 4/14/2021 | 5/2/2019 | ||
|---|---|---|---|---|---|
Exit | Reverse Merger | Acq - Fin | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 1 | 2 | 6 |
Envest Private Equity Acquisitions
2 Acquisitions
Envest Private Equity acquired 2 companies. Their latest acquisition was All Parks Insurance on April 08, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
4/8/2021 | Acq - Fin | 1 | ||||
1/25/2021 |
Date | 4/8/2021 | 1/25/2021 |
|---|---|---|
Investment Stage | ||
Companies | ||
Valuation | ||
Total Funding | ||
Note | Acq - Fin | |
Sources | 1 |
Envest Private Equity Fund History
6 Fund Histories
Envest Private Equity has 6 funds, including Envest Private Equity II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
2/18/2020 | Envest Private Equity II | $18.2M | 1 | ||
2/14/2020 | Envest Capital Partners II | ||||
12/31/2017 | Envest Capital Partners LLC | ||||
5/31/2008 | Envest Ventures III LLC | ||||
3/15/2005 | Envest Ventures II LLC |
Closing Date | 2/18/2020 | 2/14/2020 | 12/31/2017 | 5/31/2008 | 3/15/2005 |
|---|---|---|---|---|---|
Fund | Envest Private Equity II | Envest Capital Partners II | Envest Capital Partners LLC | Envest Ventures III LLC | Envest Ventures II LLC |
Fund Type | |||||
Status | |||||
Amount | $18.2M | ||||
Sources | 1 |
Envest Private Equity Team
3 Team Members
Envest Private Equity has 3 team members, including current Founder, Senior Managing Director, John Garel.
Name | Work History | Title | Status |
|---|---|---|---|
John Garel | Founder, Senior Managing Director | Current | |
Name | John Garel | ||
|---|---|---|---|
Work History | |||
Title | Founder, Senior Managing Director | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.